Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Quantum eMotion Pursues US Stock Exchange Listing

Andreas Sommer by Andreas Sommer
January 24, 2026
in AI & Quantum Computing, Cyber Security, IPOs, Penny Stocks, Tech & Software
0
Quantum eMotion Stock
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Quantum eMotion Corp. (TSXV: QNC) has taken a definitive step toward expanding its investor base by initiating the process for a US stock exchange listing. The quantum cybersecurity technology firm submitted a Form 40-F registration statement to the US Securities and Exchange Commission (SEC) on January 23, 2026, laying the groundwork for a potential dual listing on the NYSE American exchange.

Strengthening the Capital Foundation

This regulatory move follows a recent capital raise that has bolstered the company’s financial position. Quantum eMotion successfully secured approximately CA$10 million in new funding. For a development-stage company that is currently pre-revenue and reporting operating losses, these proceeds are critical. They are earmarked to support two primary objectives: financing the costly process of a US listing and advancing ongoing operational development. The company’s ability to execute its US strategy is therefore closely tied to this enhanced liquidity.

A Strategic Move for Broader Market Access

The primary goal of seeking a US listing is to improve access to American investors and enhance the stock’s overall liquidity. Currently, Quantum eMotion shares trade solely on Canada’s TSX Venture Exchange. Gaining approval for the NYSE American would represent a significant milestone, broadening the company’s profile within the North American capital markets.

It is important to note that this planned listing remains conditional upon receiving final approval from both the SEC and the NYSE American.

Should investors sell immediately? Or is it worth buying Quantum eMotion?

Institutional and Partnership Endorsement

The company’s strategic direction is gaining visibility and support. In a notable development, Quantum eMotion became one of the largest holdings in the Defiance Quantum ETF (QTUM) by the end of December 2025. This increased institutional footprint, combined with the active pursuit of a US listing, underscores a clear strategy aimed at achieving a wider market presence.

Furthermore, the SEC filing prompted a public response from a key partner. Aegis Critical Energy Defence Corp. (CSE: QESS), which collaborates with Quantum eMotion on projects like the “Tough Bhoy” quantum-secure energy storage system initiative, publicly acknowledged the filing. Aegis characterized the US listing effort as a major milestone for the technology developer.

Key Facts at a Glance

  • Regulatory Action: Form 40-F filed with the SEC on January 23, 2026.
  • Listing Target: Application for a dual listing on the NYSE American exchange.
  • Financial Status: Recent capital raise of ~CA$10 million; company is currently pre-revenue.
  • ETF Inclusion: A top holding in the Defiance Quantum ETF (QTUM) since late 2025.
  • Industry Support: Public backing from project partner Aegis Critical Energy Defence.

The Path Forward

The immediate focus now shifts to the US regulatory review process. With fresh capital in hand and heightened visibility through ETF inclusion, Quantum eMotion has positioned itself to significantly expand its standing in the North American financial landscape—pending the necessary approvals from US regulators and the exchange.

Ad

Quantum eMotion Stock: Buy or Sell?! New Quantum eMotion Analysis from February 7 delivers the answer:

The latest Quantum eMotion figures speak for themselves: Urgent action needed for Quantum eMotion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Quantum eMotion: Buy or sell? Read more here...

Tags: Quantum eMotion
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
MP Materials Stock

Conflicting Signals Emerge for MP Materials Shareholders

IREN Stock

IREN Shares Surge as Quarterly Report and AI Strategy Fuel Investor Excitement

BHP Stock

BHP Shares: A Tale of Operational Strength and Mounting Headwinds

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com